Please login to the form below
brain fog
This page shows the latest brain fog news and features for those working in and with pharma, biotech and healthcare.
COVID-19 linked to long-term neurologic disorders in new US study
Memory impairments, commonly referred to as brain fog, were the most common symptom, with those who had had the virus having a 77% higher risk of developing memory problems compared to ... A previous study in Nature Medicine led by Al-Aly found that
Latest news
-
COVID-19 linked to higher risk of brain fog, dementia and psychosis in new study
People who have had COVID-19 face a higher risk of developing neurological and psychiatric conditions including cognitive deficit – known as brain fog – dementia and psychosis as much as two years ... The study found that adults aged 64 and under had
-
Tonix Pharmaceuticals to develop TNX-102 for long COVID syndrome
In a statement, Tonix said that long COVID syndrome symptoms – including pain, sleep disturbance, fatigue and brain fog – overlap with fibromyalgia, another long-term condition characterised by widespread musculoskeletal pain. ... Long COVID has been
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Mental health post-COVID-19: what are the consequences and lessons learned for healthcare?
Debilitating ‘long COVID’, estimated to affect at least 65 million people worldwide, is associated with neuropsychiatric sequelae such as fatigue, brain fog, memory loss, anxiety and depressive symptoms, and likely contributes
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
For example, the mental symptoms such as brain fog can be extremely debilitating but are rarely talked about.
-
WHITE PAPER: What's missing in women's health?
Changes to the mind and body can mean that women no longer feel ‘like themselves’ alongside experiencing debilitating brain fog and even spells of depression. ... find out, what it does to our brain. Front Neurosci. 2014; 8.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Rare diseases: not so rare after all
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- NHS England announces rare genetic disorder fast-tracking service
- NICE sees ‘promise’ in four UTI tests that could help in fight against AMR
- Connectome competitiveness
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- Sobi’s Kineret granted FDA Emergency Use Authorisation for COVID-19 related pneumonia
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
